Back to top
more

High Tide (HITI)

(Real Time Quote from BATS)

$1.99 USD

1.99
584,828

-0.04 (-1.97%)

Updated Apr 29, 2024 03:40 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (142 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Riya Anand headshot

How You Should Play Hologic (HOLX) Ahead of Q2 Earnings

by Riya Anand

Hologic's (HOLX) second-quarter 2024 earnings will likely reflect gains from the GYN surgical business and the growing adoption of Panther instruments.

Moumi Mondal headshot

Should Lifeward (LFWD) be in Your Portfolio Ahead of Q1 Earnings?

by Moumi Mondal

Lifeward's (LFWD) first-quarter 2024 results are expected to reflect the benefits of several milestone achievements from last year.

High Tide Inc. (HITI) Advances While Market Declines: Some Information for Investors

by Zacks Equity Research

High Tide Inc. (HITI) closed at $2.03 in the latest trading session, marking a +0.5% move from the prior day.

Hologic (HOLX) Q2 Earnings Might Rise on GYN Surgical Growth

by Zacks Equity Research

Hologic's (HOLX) second-quarter fiscal 2024 performance is likely to be driven by the GYN Surgical portfolio.

The Zacks Analyst Blog Highlights Comfort Systems, High Tide, CuriosityStream and Turtle Beach

by Zacks Equity Research

Comfort Systems, High Tide, CuriosityStream and Turtle Beach are included in this Analyst Blog.

High Tide Inc. (HITI) Declines More Than Market: Some Information for Investors

by Zacks Equity Research

In the closing of the recent trading day, High Tide Inc. (HITI) stood at $2.21, denoting a -1.34% change from the preceding trading day.

Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?

by Zacks Equity Research

The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.

High Tide (HITI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

by Zacks Equity Research

High Tide (HITI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Tirthankar Chakraborty headshot

US Economy is Booming in 2024: Here's How to Trade It

by Tirthankar Chakraborty

With the U.S. economy on a hot streak, it makes sense to invest in growth stocks such as Comfort Systems USA (FIX), High Tide (HITI), CuriosityStream (CURI) and Turtle Beach (HEAR).

Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings?

by Zacks Equity Research

The strong adoption of transcatheter heart valves is expected to have led to Edwards Lifesciences' (EW) growth in the first quarter.

Hologic (HOLX) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.

Benjamin Rains headshot

How to Find Cheap Stocks Under $10 to Buy Now

by Benjamin Rains

Along with the cheap price tags, the stocks we learn how to search for earn strong Zacks Ranks, driven by improving earnings outlooks. On top of that, Wall Street is high on all of these stocks.

Align Technology (ALGN) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Align Technology's (ALGN) first-quarter 2024 performance is likely to reflect the strength of the Clear Aligner and Systems & Services businesses.

What's in Store for Boston Scientific (BSX) in Q1 Earnings?

by Zacks Equity Research

Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America.

What's in Store for Thermo Fisher (TMO) in Q1 Earnings?

by Zacks Equity Research

Strength in Analytical Instrument and Laboratory Products and Services segments are likely to have driven Thermo Fisher's (TMO) first-quarter 2024 performance.

What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?

by Zacks Equity Research

Abbott (ABT) is likely to have progressed with its initiative to commercialize several biosimilars in emerging markets.

Wall Street Analysts See High Tide (HITI) as a Buy: Should You Invest?

by Zacks Equity Research

According to the average brokerage recommendation (ABR), one should invest in High Tide (HITI). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

High Tide Inc. (HITI) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

High Tide (HITI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

High Tide (HITI) Moves to Strong Buy: Rationale Behind the Upgrade

by Zacks Equity Research

High Tide (HITI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Best Momentum Stocks to Buy for April 2nd

by Zacks Equity Research

HITI, MPC and SIGA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 2, 2023.

New Strong Buy Stocks for April 2nd

by Zacks Equity Research

CXDO, HITI, SIGA, CPG and CTKB have been added to the Zacks Rank #1 (Strong Buy) List on April 2, 2023.

High Tide (HITI) Acquires Queen of Bud to Expand Its Portfolio

by Zacks Equity Research

High Tide (HITI) announces the acquisition of Queen of Bud to boost its in-house cannabis brand portfolio without burdening its significant capital expenditure.

High Tide Inc. (HITI) Reports Break-Even Earnings for Q1

by Zacks Equity Research

High Tide Inc. (HITI) delivered earnings and revenue surprises of 100% and 0.36%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?

High Tide Inc. (HITI) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

High Tide Inc. (HITI) delivered earnings and revenue surprises of 166.67% and 1.07%, respectively, for the quarter ended October 2023. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Green Thumb Industries Inc. (GTBIF): Can Its 10.6% Jump Turn into More Strength?

by Zacks Equity Research

Green Thumb Industries Inc. (GTBIF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.